#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study to Examine Distribution of Aromatase Inhibitor and Ribociclib in ER+ HER2- Early Breast Cancer in Postmenopausal Women Scheduled for Surgery

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Cyprus France Poland Slovenia Spain

  • Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Croatia

  • Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Italy Spain

  • Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy Portugal Spain

  • Study on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Italy The Netherlands Poland Spain

  • Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium France

  • Study on Abemaciclib and Endocrine Therapy for Patients with Advanced Hormone Receptor Positive HER2 Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Germany